ERBB2 and cholangiocarcinoma: Besides that, we found that 12 CCA PDPCs derived from three patients were identified to carry the mutations of recurrently putative driver genes including TP53, KMT2C, ERBB2, and JAK3 (Supplementary Fig. 5).